GLO1 and neoplasm: The potential complication of cytotoxic off-target effects in the surrounding non-tumor brain tissue (neurons, astrocytes, and oligodendrocytes) resulting from GLO1 inhibition was investigated using quantitative immunohistochemistry to assess markers of apoptosis and neural fitness.